Prasugrel

LE WE PMID CA

Prasugrel

3216

Prasugrel

AJW200

ALX 0081

ARC1779

Atherothrombosis

Cangrelor

Clopidogrel

Elinogrel

Heart (Coronary heart disease BASKET)

P2Y12

PAR1

Platelets (Therapeutic inhibitors)

Prasugrel

Terutroban

Ticagrelor

Ticlopidine

2010 1	What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel. [20211848] QJM 103(6): 367-77 (2010)
2008 2	Will prasugrel supersede clopidogrel for acute coronary syndromes? [18393737] Med J Aust 188(7): 381-2 (2008)
2007 3	Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile. [18078435] Cardiovasc Drug Rev 25(4): 357-74 (2007)
2009 4	Prasugrel: a novel platelet ADP P2Y receptor antagonist. [19689619] Cardiovasc Ther 27(3): 194-8 (2009)
2009 5	Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. [19898643] Vasc Health Risk Manag 5(-): 873-82 (2009)
2009 6	Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel. [19475783] Vasc Health Risk Manag 5(1): 475-81 (2009)
2009 7	Prasugrel for the treatment of patients with acute coronary syndrome. [19436677] Vasc Health Risk Manag 5(1): 321-4 (2009)
2009 8	Review of prasugrel for the secondary prevention of atherothrombosis. [19496635] J Manag Care Pharm 15(5): 383-95 (2009)
2009 9	Critical review of prasugrel for formulary decision makers. [19422273] J Manag Care Pharm 15(4): 335-43 (2009)
2010 10	Prasugrel. [20660815] Circulation 122(4): 394-403 (2010)
2008 11	Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel. [18852375] Circulation 118(16): 1607-8 (2008)
2009 12	P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. [19633016] Eur Heart J 30(16): 1964-77 (2009)
2010 13	Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. [20050853] Br J Pharmacol 159(3): 502-17 (2010)
2010 14	Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention. [20507801] Health Technol Assess 14 Suppl 1(-): 31-8 (2010)
2009 15	Pharmacy benefit spending poised to increase for antithrombotic drug therapy -- prasugrel versus clopidogrel. [19496638] J Manag Care Pharm 15(5): 414-6 (2009)
PMC 16	Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. [C3860827] Indian Heart J 65(2):226-8 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Prasugrel.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Prasugrel.php on line 92